ABSTRACT Parameters of vitamin B-6 metabolism were studied in pregnant rats, nonpregnant control rats and pro gesterone-supplemented ovariectomized rats. Plasma pyridoxal 5'-phosphate (PLP) and pyridoxal concentrations in pregnant rats were 20 and 40% of those of nonpregnant rats, respectively. Excretion of 4-pyridoxic acid in the urine in pregnant rats was about 40% of that of nonpregnant rats. Liver PLP content was also lower during pregnancy, but liver pyridoxamine 5'-phosphate (PMP), kidney PLP and PMP and muscle PLP contents did not change sig nificantly. Progesterone administration to ovariectomized rats resulted in slightly lower plasma, liver and kidney PLP levels than in intact untreated control rats. Liver and kidney pyridoxal kinase (PK) and pyridoxamine 5'-phosphate ox idase activities were similar in pregnant and nonpregnant rats. Progesterone treatment resulted in a significantly lower PK activity in the kidney of the treated rats than in untreated controls. It is concluded that the pregnancy-induced changes in vitamin B-6 metabolism were unlikely to be related di rectly to progesterone. However, progesterone may sec ondarily affect maternal vitamin B-6 stores during preg nancy, by temporary deposition and increased retention of vitamin B-6.
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Previous studies have shown that pregnancy affects some biochemical parameters of vitamin B-6 status, especially the plasma pyridoxal 5'-phosphate (PLP) con tent (1) (2) (3) (4) . In general, these pregnancy-induced changes, which have been observed in humans as well as in other species, are interpreted as indicative of an increased requirement for vitamin B-6 (1, 5) . However, pregnancy is accompanied by striking changes in the "milieu in tÃ©rieur" resulting in temporary changes in maternal metabolism and regulatory control mechanisms (6, 7) . This has been most clearly demonstrated with respect to the energy and protein metabolism. Naismith and Morgan (7, 8) postulated a biphasic nature of protein metabolism during pregnancy in the rat, mediated by a changing hormonal environment. Estrogens as well as progesterone are thought to play a role in the change over from an anabolic to a catabolic-oriented metabolic state in the course of pregnancy.
As hormones may also affect vitamin B-6 metabolism (9-13) one wonders to what extent the pregnancy-in duced changes in parameters of the vitamin B-6 status could be explained by the changing hormonal environ ment. Although the effect of estrogens on vitamin B-6 metabolism has been studied extensively (9, 10) , the effect of progesterone has, to our knowledge, received no or only slight attention.
Therefore we studied the effect of pregnancy and of progesterone administration in the rat on changes in the concentration of plasma PLP, on the liver, kidney and muscle PLP and pyridoxamine 5'-phosphate (PMP) contents, as well as on the activities of some vitamin B-6-metabolizing enzymes.
MATERIALS AND METHODS

Animals and Diets
Two experiments were performed. In the first exper iment the effect of pregnancy was studied and in the second one the effect of progesterone.
Experiment 1: effect of pregnancy. At the beginning of the experiment 60 female 9-wk-old virgin Wistar (Cpb:WU) rats (obtained from the Central Institute for the Breeding of Laboratory animals TNO, Zeist, The Netherlands) were housed in groups of six in stainless steel cages in a well-ventilated room at a temperature To whom correspondence should be addressed.
0022-3166/87 $3.00 Â©1987 American Institute of Nutrition. Received 13 January 1987. Accepted 27 July 1987. of 23 Â±TG, a relative humidity of 50 Â±10% and a light-dark cycle of 12 h. The rats were fed a purified diet providing 3 mg pyridoxine-HCl/kg diet (Table 1) . After a feeding period of 4 wk the rats were mated, which was confirmed by the presence of sperm in va ginal smears. The day on which a positive vaginal smear was found was considered as d 0 of gestation, and from that day on rats were housed individually. The re maining nonmated rats served as nonpregnant controls. To maintain a comparable pyridoxine and protein in take between pregnant and nonpregnant rats, the preg nant rats were fed (from d 0) a modified isoenergetic diet containing reduced amounts of all nutrients, ex cept wheat starch, and providing 1.9 mg pyridoxineHCl/kg diet (Table 1) . This difference in diet compo sition was based on an average increase in food con sumption during pregnancy of about 40% as compared with the nonpregnant state. In this way the intake of essential nutrients was also comparable for the two groups. On d 7, 14 and 20 of gestation seven pregnant and seven nonpregnant rats were killed by decapitation (between 0900 and 1000 h) and blood and tissue samples were collected as described below.
Experiment 2: effect of progesterone. Thirty female 10-wk-old virgin Wistar rats (Cpb:WU) were randomly assigned to three groups (groups 1-3) of 10 rats each. Rats were housed in groups of five in stainless steel cages under the same conditions as in experiment 1. After a short acclimatization period the animals of groups 2 and 3 were ovariectomized bilaterally. Three weeks later a Silastic capsule was implanted subcutaneously in all animals [for experimental details see Karsch et al. (14) ]; the capsule consisted of eight 5-cm pieces of Silastic medical-grade tubing (3.35 mm i.d. x 4.70mm o.d., Dow-Corning, Midland, MI). In groups 1 ( -OVX/ -PROG) and 2 (+ OVX/ -PROG) the tubing was empty; in group 3 (+ OVX/ + PROG) the tubing was filled with crystalline progesterone. With these progesterone-con taining capsules a serum progesterone level of 110 Â± 20 ng/ml was maintained for at least 2 wk. During rat pregnancy progesterone levels increase up to values of about 100 ng/ml. Fourteen days after capsule implan tation, the rats were killed by decapitation. Starting 1 wk before implantation, all animals were kept under the same experimental conditions and fed the same purified diet as given to the pregnant rats described in experiment 1. During the acclimatization period until 1 wk before implantation all rats were fed the regular CIVO stock diet containing 12 mg pyridoxine/kg diet.
Preparation of Samples
Blood was collected from the orbital plexus directly into tubes containing 20 |xl EDTA (80 g/l), pH 7.4. Immediately after collection, blood samples were centrifuged at 1700 x g for 15 min (4Â°C). Plasma was sep arated and stored at -20Â°C until analysis. Urine (24 h) was collected in plain plastic vials kept on dry ice (-76Â°C). Liver, kidney, the right gastrocnemius muscle and, in experiment 1, the uterus and the total concep tual product (fetoplacental mass) were dissected out. Tissue extracts were prepared as described before (15) and stored at -20Â°Cuntil analysis.
Analysis
The pyridoxal kinase (PK; EC 2.7.1.35) activity in liver and kidney homogenates was measured according to the method described by Chern and Beutler (16) . The pyridoxamine-5'-phosphate oxidase (PPO; EC 1.4.3.5) activity was determined by the method described by Wada and Snell (17) with slight modifications. Plasma and tissue PLP contents were determined radioenzymatically using the tyrosine decarboxylase apoenzyme assay as described by Chabner and Livingstone (18) . The tissue PMP content was measured as PLP after nonenzymatic transamination of PMP with glyoxylic acid (19) . The 4-pyridoxic acid concentration in urine was determined by high performance liquid chromatography (HPLC) with fluorometric detection according to Gregory and Kirk (20) . The vitamin B-6 content of the diet was measured by a microbiological assay with Saccharomyces carlsbergensis (ATCC 9080). Protein con tent was determined by the method of Lowry et al. (21) using bovine serum albumin as reference.
Statistical Analysis
All data were analyzed by computer using analysis of variance. In the first experiment a 2 x 3 factorial design was used with the factors group (pregnant/nonpregnant) and day (7, 14 and 21). Data from the second experiment were subjected to one-way analysis of var-'Values are means for n = 10. 2SED, standard error of difference. 3NS, not significant.
iance with the factor group ( -OVX/ -PROG; + OVX/ -PROG; + OVX/ + PROG). For all parameters inves tigated the standard error of the differences between means (SED)was calculated, and these SED values are given in the tables. With the aid of the SED, t-values can be calculated by dividing the differences between two means by the corresponding SED.In the figures the least significant difference (LSD) is indicated. The LSD was calculated as the product of the SEDand the i-value corresponding to a significance limit of P < 0.05. The LSD represents the minimal distance between two points to be significantly different (P < 0.05). Tables 2 to 4 and Figs. 1 and 2. The mean average food consumption by the pregnant rats was 17 Â±0.8 g/d, compared to 13 Â±0.8 g/d for the nonpregnant rats. In spite of the modified food com position the average pyridoxine intake was slightly dif ferent between these groups, i.e., 39 jjig/d for the nonpregnant and 32 (xg/d for the pregnant rats. Differences between groups were significant (P < 0.001) for both the food consumption and the pyridoxine intake, but TABLES Kidney PLP and PMP content and kidney PK and PPO activity of pregnant (P)and nonpregnant Â¡NP) rats' within each group food intake showed no significant change between days.
TABLE2
Liver PLP and PMP content and liver PK and PPO activity of pregnant (P)and nonpregnant (NP) rats1
RESULTS
Effect of pregnancy (experiment 1). Results of this experiment are given in
Body and liver weights increased as a result of preg nancy, but kidney weights remained constant and were not significantly different between the pregnant and nonpregnant rats (Fig. 1) . After 2 wk of pregnancy the fetoplacental mass contributed about 15% to the total body weight gain. After 3 wk, at the end of pregnancy, this contribution had increased to 50%.
The plasma PLP content was already significantly lower on d 7 of pregnancy than in the nonpregnant control group, and it continued to decrease during the entire pregnancy period (Fig. 2A} . A concomitant de crease of the plasma pyridoxal level was found, al though to a somewhat lesser degree (Fig.IB}. A similar pattern was observed for the 4-pyridoxic acid excretion (Fig. 2C) .
The liver PLP concentration gradually decreased dur ing pregnancy, while PMP levels remained relatively constant (Table 2) . However, liver PMP levels were sig nificantly lower in the pregnant animals than in the control animals. As a consequence, the PLP-PMP ratio decreased for the pregnant animals but remained con stant or increased slightly for the control animals. Tak ing into account the increase in liver weight, the total amount of liver PLP decreased (from 210 to 175 nmol) while the total amount of PMP tended to increase (from 166 to 196 nmol). As a result the "overall" vitamin B-6 content of the liver remained relatively constant dur ing pregnancy. The average activities for the vitamin B-6-metabolizing enzymes PK and PPO in liver of preg nant rats were not significantly different from those observed for the nonpregnant control group, except for a slightly higher mean liver PK activity. Protein con tent of the liver was slightly lower for the pregnant animals than for the nonpregnant controls.
The kidney PLP and PMP concentrations and the total average kidney PLP plus PMP contents were sig nificantly lower for the pregnant animals than for the nonpregnant control group (Table 3) . Between days, small but significant differences were found, but no signifi cantly different trend between the two groups was ap parent. Mean kidney PPO and PK activities and kidney protein content during pregnancy were not affected.
The muscle PLP content was not significantly dif ferent between the two groups, although muscle PMP content tended to be slightly but significantly lower for the pregnant animals ( Table 4 ). The amounts of PLP and PMP accumulated in the fetoplacental unit were similar, i.e., about 85 nmol on d 20. The amount of PLP and PMP accumulating in the uterus/ovaries dur ing pregnancy was relatively small (Table 4) . Tables 5-7 and Fig. 3 . The average daily food (pyridoxine) consumption of the control rats (group 1) was slightly lower than that of the ovariectomized rats (groups 2 and 3) ( Table 5 ). Progesterone adminis tration had no (supplemental) effect on food consump tion and thus on the pyridoxine intake in the ovariec tomized rats.
Effect of ovariectomy and progesterone administra tion (experiment 2). The results of this experiment are summarized in
The higher average body and liver weights of groups 2 and 3 ( Table 5 ) before implantation can be explained by the fact that ovariectomy was performed 3 wk before progesterone treatment. The average kidney weight of the progesterone-treated rats (group 3) was significantly higher than that of the rats receiving no progesterone (groups 1 and 2).
Liver PLP, but not PMP, was slightly lower for the progesterone-treated rats than for the other two groups. However, the liver PLP + PMP level was not signifi cantly different among the three groups. As a conse quence of the higher liver weights in the ovariectom ized animals, the total amounts of PLP and PMP accumulated in the liver were significantly higher for both the ovariectomized and the progesterone-treated rats than for the nonovariectomized control animals (Table 6 ). Liver PK and PPO activities were not affected by either ovariectomy or progesterone treatment.
As indicated in Table 7 , ovariectomy resulted in slightly lower kidney PLP levels. Because of the higher kidney weights, especially for the progesterone-treated rats, total kidney PLP and PMP contents were signifi cantly higher for the progesterone-treated rats than for the intact untreated rats. Kidney PK activity was sig nificantly lower for the progesterone-treated ovariectomized rats than for the other two groups, while kid ney PPO activity was not significantly different among the three groups.
The changes in plasma PLP and pyridoxal content, as well as in 4-pyridoxic acid urinary excretion, are shown in Fig. 3 . Plasma PLP showed a difference in trend between the progesterone-treated rats (group 3) and the animals of the other two groups (groups 1 and 2). Within this group the difference in plasma PLP con tent between d 0 and 7, but not between d 7 and 14, was significant (P = 0.04). For plasma pyridoxal a sim ilar trend was observed for all groups (Fig. 3ÃŸ) . Urinary 4-pyridoxic acid excretion showed an unexpected and unexplained decrease between d 0 and 7 for all groups.
DISCUSSION
One aim of this study was to find an explanation for the pregnancy-induced changes in vitamin B-6 status parameters. In general, our results confirm trends al ready found by other investigators (2-4, 22, 23) . How ever, some discrepancies emerge with respect to pre viously reported data. An increase in liver PLP during pregnancy was reported by Nakahara et al. (3) , but in a more recent study Reithmayer et al. (4) could not demonstrate any significant difference in liver vitamin B-6 content between pregnant and nonpregnant rats fed diets with a pyridoxine content varying between 1 and 48 jjig/g. Our data for the muscle PLP content are sim ilar to those reported by Kirksey, Pang and Lin (22), who observed no significant difference in muscle PLP content between pregnant and nonpregnant rats at var ious levels of pyridoxine intake, whereas Reithmayer et al. reported lower PLP levels in muscle of pregnant rats fed diets with a pyridoxine content below 6 mg/ kg. Such discrepancies may, at least partly, be explained by different experimental conditions, differences in strain and age of the animals used and different analytical techniques. Another complicating factor is the gener ally higher food (and pyridoxine) intake in pregnant as compared with nonpregnant rats. We (partially) circum vented the latter problem by feeding the nonpregnant control rats an "enriched" isoenergetic diet, providing about the same amount of nutrients, including pyri doxine and protein ( Table 1 ). The diets fed the pregnant and control animals provided for all minerals and vi tamins at least the amount recommended by the Na tional Research Council (NRC) for rats (24) . Only for zinc the amounts provided were slightly below these recommendations.
The actual zinc content in the diet was not determined, but it is unlikely that zinc defi ciency was involved in our studies, as no growth depres sion and no abnormalities of the skin and hair coat were observed. The pyridoxine content was also lower than the NRC recommendation (6 mg/kg). The lower pyridoxine content was chosen because under condi tions of "marginal" supply homeorhetic control mech anisms (25) leading to mobilization and (re)distribution of maternal PLP stores might be active. A marginal pyridoxine supply was also thought to better reflect the human situation. The estimated vitamin B-6 intake reported in most studies with healthy pregnant women living in industrialized (Western) societies, varies be tween 1 and 1.5 mg/d, while the NRC recommendation (9th revised edition, 1980) is 2.5 mg/d. The recommen dation for vitamin B-6 for pregnant rats is mainly based on data on (maximum) tissue vitamin content and en zyme activities (24) . Driskell and Kirksey (26) have shown that the pyridoxine requirements for pregnant rats vary between 15 and 20 p.g daily. It was concluded that the amount of vitamin B-6 provided in this study (1.9 and 3 mg/kg for the pregnant and nonpregnant rats, pro viding on average 32 and 39 |j.g daily, respectively) was adequate for successful reproductive performance. In addition, no abnormalities of the skin or other vitamin B-6 deficiency symptoms were observed.
Our data seem to confirm the pregnancy-induced de pletion of maternal vitamin B-6 stores in favor of placental transfer to the fetus. However, the difference in response between the various maternal compartments, as well as the magnitude of the actual amount of vi tamin B-6 transferred to the fetal compartment, de serves further comment. In general, muscle tissue is considered to be a storage compartment for vitamin B-6 (27) . One would therefore expect a decrease in muscle PLP content in the course of pregnancy. However, as shown in Table 4 , such a decrease did not occur. This raises the question of the relevance of muscle mass as a vitamin B-6 depository in the pregnant state. The physiological relevance of the muscle vitamin B-6 stores has been questioned before (28) . Black et al. (28) concluded from experiments with pyridoxine-deficient rats that PLP is released only when muscle protein is catabolized, e.g., during starvation, but not by vitamin B-6 deficiency per se.
Naismith and Morgan (8) reported evidence for a biphasic nature of protein metabolism during pregnancy in the rat. Although no net gain of protein results from pregnancy, until d 14 a substantial retention of nitrogen occurs, representing an increase of 8.5% in lean tissue mass. During the last week of pregnancy this "extra" muscle protein store is again catabolized, resulting in a massive transfer of amino acids and vitamin B-6 (PLP) from the maternal to the fetal tissues. Consequently, the vitamin B-6 (PLP) body store will increase in par allel with the temporary increase in muscle mass, while muscle PLP content does not change. Since, to our knowledge, no data on the absolute increase in muscle mass for the pregnant rat are available, one can only speculate about the increase in vitamin body stores. An extra 10 g of newly synthesized muscle tissue will con tain an amount of PLP + PMP similar to that accu mulating in the conceptual product (Table 4) .
From the decrease in urinary 4-pyridoxic acid excre tion while dietary pyridoxine intake remains constant, increased vitamin B-6 retention during pregnancy is obvious. In the nonpregnant state about 40% of the dietary pyridoxine is excreted as 4-pyridoxic acid. Dur ing pregnancy this percentage decreases from about 30 in the first week to about 20 in the last week of preg nancy. From these data an extra retention of about 30 nmol of vitamin B-6 per day during the last week of pregnancy can be roughly estimated.
Higher retentive capacity and/or temporary deposi tion in newly synthesized lean tissue (muscle) may therefore be operative in "channeling" vitamin B-6 (PLP/ PMP) to the fetus without seriously affecting maternal stores.
Progesterone exerts a direct anabolic effect in the intact female rat (29) and is thought to play an impor tant role in metabolic control in early pregnancy (7) . Our data indicate that this hormone has no significant effect on PLP (PMP) tissue content or on the activities of vitamin B-6-metabolizing enzymes, except for a slight decrease in plasma and liver PLP content and a some what lower PK activity in the kidney.
However, the trends observed for the liver and kidney PLP levels and total organ content indicate an (ana bolic) change similar to that observed in pregnant rats. Urinary 4-pyridoxic acid excretion showed a decrease in the first week of treatment for all three groups. This was expected for the progesterone-treated and ovariectomized rats but not for the control animals. The high est excretion levels were observed for the ovariectomized rats not treated with progesterone. These results are not easy to explain. Ovariectomy has a strong an abolic effect in rats (30) exemplified by increased food consumption and weight gain, but these data show that progesterone treatment had no "supplemental" ana bolic effect. The slight but significant decrease in plasma PLP content observed in the first week of progesterone treatment may reflect a specific effect of progesterone on the partitioning of vitamin B-6. Most of the observed hormone-induced effects on vi tamin B-6 metabolismâ€"for instance, as described for testosterone (11) and the gonadotropic hormones (12)â€" are explained by changes in the (in vitro) activity of PPO, an enzyme that plays an important regulatory role in vitamin B-6 metabolism (31). Secondary or indirect effects of hormones may be related to inhibition of PLPdependent enzymes (10), induction of vitamin B-6-dependent enzymes (9) or changes in enzyme turnover (13) .
Although some questions remain unanswered, we conclude from the results obtained in experiments 1 and 2 that 1}progesterone exerts no direct (specific) effect on vitamin B-6 metabolism and 2} the pregnancyinduced changes in parameters of the vitamin B-6 me tabolism/status cannot be explained by direct hor monal effects but probably reflect a higher retentive capacity and temporary deposition of vitamin B-6 stores in early pregnancy (the anabolic phase), secondary to the (hormone-induced) changes in protein metabolism.
Further studies are needed to demonstrate such a biphasic pattern of vitamin B-6 metabolism during pregnancy and to delineate the mechanisms involved in the regulation of vitamin B-6 distribution, transport and storage.
